PIPA520099
Avian Influenza HA Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA520099-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA520099 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
Avian Influenza HA
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
Avian Hemagglutinin; flu hemagglutinin; influenza a; Influenza HA; influenza hemagglutinin
Immunogen
A synthetic peptide corresponding to 15 amino acids at the amino terminus of the avian influenza hemagglutinin protein
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C
Form
Liquid
Applications
ELISA, Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Related Products
Description
- A suggested positive control is Hemagglutinin HA1 recombinant protein
- PA5-20099 can be used with blocking peptide PEP-0217
- Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA
- In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States
- The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic
- Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins
- The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release
- These proteins also elicit immune responses that prevent infection or independently reduce viral replication
- The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin
- The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.